Matsumoto Takayuki, Tostes Rita C, Webb R Clinton
Department of Physiology, Georgia Health Sciences University, 1120 Fifteenth Street, CA-3135, Augusta, GA 30912-3000, USA.
Adv Pharmacol Sci. 2011;2011:435132. doi: 10.1155/2011/435132. Epub 2011 Nov 1.
The endothelium plays a pivotal role in vascular homeostasis, and endothelial dysfunction is a major feature of cardiovascular diseases, such as arterial hypertension, atherosclerosis, and diabetes. Recently, uridine adenosine tetraphosphate (Up(4)A) has been identified as a novel and potent endothelium-derived contracting factor (EDCF). Up(4)A structurally contains both purine and pyrimidine moieties, which activate purinergic receptors. There is an accumulating body of evidence to show that Up(4)A modulates vascular function by actions on endothelial and smooth muscle cells. In this paper, we discuss the effects of Up(4)A on vascular function and a potential role for Up(4)A in cardiovascular diseases.
内皮在血管稳态中起关键作用,而内皮功能障碍是心血管疾病(如动脉高血压、动脉粥样硬化和糖尿病)的主要特征。最近,四磷酸尿苷腺苷(Up(4)A)已被鉴定为一种新型强效内皮源性收缩因子(EDCF)。Up(4)A在结构上同时含有嘌呤和嘧啶部分,可激活嘌呤能受体。越来越多的证据表明,Up(4)A通过作用于内皮细胞和平滑肌细胞来调节血管功能。在本文中,我们讨论了Up(4)A对血管功能的影响以及Up(4)A在心血管疾病中的潜在作用。